A drug called “Afotid” is already used as part of clinical studies on volunteers. According to the court, the safety of the drug was documented and the permission of the clinical work was given to seven medical centers.
The date of development is related to the contract between the Ministry of Industry and Trade and the Lina M company from the Koroleva Moscow region. The Ministry previously tried to terminate the 2014 agreement through the court and to return the results of the study with more than 117 million rubles in the advance, claiming that the results of the study were not consumer value. In addition, an important delay was declared in the performance of the work.
However, the Court of Appeal took into account that delays were caused by objective reasons: then, the test is to be developed, a pandemic and a permission for sanction restrictions. As a result, the Court admitted that despite the difficulties, the company constitutes an important drug for society.
Source: Ferra
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
